1-14 of 14
Anna Ferguson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treating MRD Positivity in Multiple Myeloma: An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Long-Term Remissions in Patients with Low Disease Burden

Luca Biavati, MD, Carol Ann Huff, MD, Anna Ferguson, BSN, RN, Lakshmi Rudraraju, MS, Cristina Zucchinetti, Rachel Gittelman, Sarah Johnson, Catherine Sanders, Abbas Abbas Ali, MD, Kimberly Noonan, PhD MPH, Ivan M. Borrello, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-142620
Published: 2020
Journal Articles

An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Durable Remissions and Sustained Immunological Responses in Multiple Myeloma

Luca Biavati, MD, Anna Ferguson, BSN, RN, Carol Ann Huff, MD, Lakshmi Rudraraju, MS, Rachel Gittelman, Sarah Johnson, Catherine Sanders, Syed Abbas Ali, MD, Kimberly Noonan, PhD MPH, Ivan M. Borrello, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1895.
https://doi.org/10.1182/blood-2019-128430
Published: 2019
Journal Articles

Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)

Tara M. Robinson, MD PhD, Hanna Knaus, MD, B Douglas Smith, MD, Andrea M.H. Towlerton, BS, Edus H. Warren, III, MDPhD, Joshua F Zeidner, MD, Amanda Blackford, Amy S. Duffield, MD PhD, David Rizzieri, MD, Mark G. Frattini, MD PhD, Moshe Levy, MD, Mark A. Schroeder, MD, Anna Ferguson, BSN, RN, Katherine Sheldon, Amy E. DeZern, MD, Ivana Gojo, MD, Steven D. Gore, MD, Howard Streicher, MD, Leo Luznik, MD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1699.
https://doi.org/10.1182/blood.V130.Suppl_1.1699.1699
Published: 2017
Journal Articles

A Randomized Phase II Trial of Interferon (IFN)/GM-CSF Versus K562/GM-CSF Vaccination in Chronic Phase CML Patients on Frontline Tyrosine Kinase Inhibitor (TKI) Therapy: Potential of IFN to Enhance Molecular Remissions

Jonathan Allen Webster, MD, Anna Ferguson, BSN, RN, Christopher Gocke, MD, Richard J Jones, MD, Hyam Levitsky, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2016) 128 (22): 3088.
https://doi.org/10.1182/blood.V128.22.3088.3088
Published: 2016
Journal Articles

Minimal Residual Disease (MRD) As Exploratory Endpoint in a Phase 1 Study of the Anti-CD123 Mab CSL362 Given As Post-Remission Therapy in Adult Acute Myeloid Leukemia (AML)

B. Douglas Smith, MD, Andrew W. Roberts, MBBS, PhD, Gail J. Roboz, MD, Mark DeWitte, VMD, Anna Ferguson, BSN, RN, Linda Garrett, RN, Tania Curcio, Kaysey F. Orlowski, Sue Dasen, MS, Debra M. Bensen-Kennedy, MD, Roland B. Walter, MD PhD MS
Journal: Blood
Blood (2015) 126 (23): 3819.
https://doi.org/10.1182/blood.V126.23.3819.3819
Published: 2015
Journal Articles

Allogeneic Myeloma GVAX with Lenalidomide Enhances Progression Free Survival through the Generation of Tumor Specific Immunity in Patients in Near Complete Remission

Ivan M. Borrello, MD, Kimberly Noonan, PhD MPH, Carol Ann Huff, Anna Ferguson, BSN, RN, Amy Sidorski, CRNP, Lakshmi Rudraraju, Raffaello Cimbro, MS, Luigi Marchionni, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4238.
https://doi.org/10.1182/blood.V126.23.4238.4238
Published: 2015
Journal Articles

Stabilization of Myelodysplastic Syndromes (MDS) Following Hypomethylating Agent (HMAs) Failure Using the Immune Checkpoint Inhibitor Ipilimumab: A Phase I Trial

Amer M. Zeidan, MBBS, MHS, Joshua F. Zeidner, MD, Amy Duffield, MD, Hanna A. Knaus, MD, Anna Ferguson, BSN, RN, Katherine Sheldon, Amy E. DeZern, MD MHS, Ivana Gojo, MD, Steven D. Gore, MD, Howard Streicher, MD, Leo Luznik, B. Douglas Smith
Journal: Blood
Blood (2015) 126 (23): 1666.
https://doi.org/10.1182/blood.V126.23.1666.1666
Published: 2015
Journal Articles

Lenalidomide Immunomodulation with an Allogeneic Myeloma GVAX in a Near Complete Remission Induces Durable Clinical Remissions

Kimberly Noonan, PhD MPH, Carol Ann Huff, Amy Sidorski, NP, Anna Ferguson, RN, Lakshmi Rudraraju, MS, Andrea Casildo, BS, Ivan Borrello, MD
Journal: Blood
Blood (2014) 124 (21): 2137.
https://doi.org/10.1182/blood.V124.21.2137.2137
Published: 2014
Journal Articles

First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse

B. Douglas Smith, MD, Gail J. Roboz, MD, Roland B. Walter, MD PhD, Jessica K. Altman, MD, Anna Ferguson, BSN, RN, Tania J. Curcio, R.N, Kaysey F. Orlowski, Linda Garrett, RN, Samantha J Busfield, PhD, Megan Barnden, PhD, Brad Sedgmen, PhD, Souravi Ghosh, PhD, Sarah Hosback, PhD, Roslyn Davis, MSc, Allison Dyson, BSc, Sue Dasen, MS, Mark DeWitte, VMD, Debra M. Bensen-Kennedy, MD, Andrew W. Roberts, MBBS, PhD
Journal: Blood
Blood (2014) 124 (21): 120.
https://doi.org/10.1182/blood.V124.21.120.120
Published: 2014
Journal Articles

Dissecting The Potential Role Of Prevnar As An Anti-Myeloma Vaccine

Kimberly Noonan, PhD, MPH, Lakshmi Rudraraju, MS, Anna Ferguson, RN, Amy Sidorski, NP, Andrea Casildo, BS, Ervin Griffin, Susan Lee, BS, Nilanjan Ghosh, MD, PhD, William Matsui, MD, Carol Huff, M.D., Ivan M. Borrello, MD
Journal: Blood
Blood (2013) 122 (21): 1980.
https://doi.org/10.1182/blood.V122.21.1980.1980
Published: 2013
Journal Articles

Lenalidomide Augments Immune Responses to Prevnar Vaccination in Relapsed Myeloma Patients: Implications for Cancer and Infectious Vaccines.

Kimberly Ann Noonan, MPH, BS, Anna Ferguson, RN, Amy Emerling, Lakshmi Rudraraju, M.S., Carol A. Huff, MD, Peter H Schafer, Ivan M. Borrello, MD
Journal: Blood
Blood (2009) 114 (22): 1864.
https://doi.org/10.1182/blood.V114.22.1864.1864
Published: 2009
Journal Articles

Bortezomib and Thalidomide, a Steroid Free Regimen in Newly Diagnosed Patients with Multiple Myeloma.

Nilanjan Ghosh, Anna Ferguson, RN, Xiaobu Ye, Carol A. Huff, MD, Ivan M. Borrello, MD
Journal: Blood
Blood (2009) 114 (22): 2867.
https://doi.org/10.1182/blood.V114.22.2867.2867
Published: 2009
Journal Articles

The Immunomodulatory Role of Lenalidomide on Prevnar ® Responses in Patients with Relapsed Multiple Myeloma: A Comprehensive Analysis of the Immune Response

Kimberly Ann Noonan, MPH, BS, Anna Ferguson, RN, Carol A. Huff, MD, Amy Emerling, Stephanie Mgebroff, Rose Wilson, Robert D. Knight, MD, Ivan M. Borrello, MD
Journal: Blood
Blood (2008) 112 (11): 2772.
https://doi.org/10.1182/blood.V112.11.2772.2772
Published: 2008
Journal Articles

Bortezomib and Thalidomide Treatment of Newly Diagnosed Patients with Multiple Myeloma - Efficacy and Neurotoxicity.

Ivan Borrello, MD, Anna Ferguson, RN, Carol Ann Huff, MD, Shirley George, BS, Barbara Biedryzcki, CRNP, David Cornblath, MD, Vinay Chaudhry, MD
Journal: Blood
Blood (2006) 108 (11): 3528.
https://doi.org/10.1182/blood.V108.11.3528.3528
Published: 2006